EXOSKELETON MARKET: OVERVIEW
The global exoskeleton market is valued at USD 3.7 billion in the current year and is projected to reach USD 20.3 billion by 2035, representing a CAGR of 20.8% during the forecast period. The exoskeleton market size is being propelled by the convergence of two previously distinct demand streams namely clinical rehabilitation for neuromotor impairment and occupational ergonomics for industrial workforces, both of which are increasingly served by the same underlying wearable robotics platforms.Exoskeleton Market: Growth and Trends
Mobility impairment has become one of the defining clinical and economic burdens of modern healthcare systems. Neurological conditions are now among the leading causes of disability worldwide, and the World Health Organization reported in 2025 that such conditions affect more than 40% of the global population, equivalent to over 3 billion people, and contribute to more than 11 million deaths annually. As this burden grows, health systems are looking beyond passive mobility aids such as wheelchairs, walkers, and crutches, toward technologies that can support active functional recovery.In order to address this concern, exoskeletons have emerged as a next-generation solution. These wearable robotic systems integrate sensors, motors, actuators, control software, and power units to assist standing, walking, balance, and limb movement in individuals affected by stroke, spinal cord injury, multiple sclerosis, acquired brain injury, and other neuromotor conditions. Recently, Ekso Bionics reports that its exoskeleton technology is deployed across more than 500 rehabilitation centers globally. Further, its EksoNR platform holds FDA clearance for brain injury and multiple sclerosis, in addition to being the first exoskeleton cleared for both stroke and spinal cord injury rehabilitation.
A pivotal development reshaping market access has been the build-out of a Medicare reimbursement pathway for personal exoskeletons in the United States. For instance, Lifeward disclosed that Aetna, Humana, and UnitedHealthcare had extended Medicare Advantage coverage to the ReWalk Personal Exoskeleton, opening potential access to roughly 16 million covered individuals. The company also noted that Q4 FY2025 revenue from ReWalk Personal Exoskeleton sales rose 20% year-on-year, driven largely by higher volumes of reimbursed units. Expanding payer coverage of this kind lowers reimbursement uncertainty, improves affordability for eligible patients with spinal cord injury, and accelerates the shift of exoskeleton adoption from institutional rehabilitation settings toward home and community use.
Growth Drivers: Strategic Enablers of Exoskeleton Market Expansion
Growth in the exoskeleton market is being driven by a fundamental shift from passive mobility support toward active, technology-enabled functional recovery. Conventional aids such as wheelchairs, walkers, and crutches compensate for lost mobility but do not retrain movement patterns. Exoskeletons, in contrast, actively assist standing, walking, balance, and repetitive limb movement, positioning them as an attractive investment for hospitals and rehabilitation centers seeking to raise therapy intensity, support neuroplasticity, and increase patient engagement in recovery programs.Further, technological advancement across sensors, artificial intelligence, control systems, and lightweight materials is supporting market growth. Continued improvement in motion sensors, AI-enabled control software, battery systems, actuators, and ergonomic design is making exoskeleton systems more responsive, safer, and easier to deploy across clinical, homecare, and industrial environments alike. Emerging research into data-driven, adaptive assistance for post-stroke gait training is a further sign of the market's direction, with wearable systems increasingly able to adjust support levels in real time based on patient-specific movement data.
Market Challenges: Critical Barriers to Exoskeleton Market Growth
Despite strong momentum, the exoskeleton market continues to face structural barriers that could temper the pace of adoption. Patient eligibility remains a central constraint: suitability for exoskeleton-assisted therapy can depend on height, weight, bone density, cardiovascular health, balance, upper-body strength, spasticity, cognition, skin condition, and level of injury. This narrows the addressable patient population and complicates manufacturers' efforts to scale adoption, since personal exoskeletons designed for spinal cord injury, for instance, may not suit every user with severe paralysis or complex comorbidities.Reimbursement remains equally consequential. While the US has made measurable progress by classifying certain powered exoskeletons under the Medicare brace-benefit category, coverage still hinges on eligibility criteria, documentation requirements, prior authorization, payer-specific policy, and clinical justification. In many other geographies, reimbursement pathways remain undefined or limited, restricting broader adoption of medical exoskeletons beyond select rehabilitation centers and self-funded patients.
Exoskeleton Market: Key Insights
The report delves into the current state of the exoskeleton market and identifies potential growth opportunities within the industry. Some of the key findings include:
- Healthcare Drives Commercial Adoption: More than 500 Ekso Bionics exoskeletons are currently deployed across 30+ countries, highlighting the growing clinical footprint of rehabilitation exoskeletons.
- Powered Exoskeletons Lead Market Adoption: Powered systems remain the leading technology category as active motor-assisted movement expands across rehabilitation and industrial applications.
- Industrial Deployment Is Scaling: Airbus is testing 118 exoskeletons across France, Spain and Canada for shoulder, neck, lumbar and knee applications, demonstrating growing adoption beyond healthcare.
- Measured Ergonomic Benefits Support Industrial Demand: Airbus trials recorded a 10% to 40% reduction in shoulder and upper-back muscular strain among paint-shop operators using exoskeletons.
- Reimbursement is Expanding the Addressable Market: Coverage for the ReWalk Personal Exoskeleton across Aetna, UnitedHealthcare and Humana potentially extends access to approximately 16 million US beneficiaries.
- Regulatory Activity is Supporting Commercialization: Recent FDA clearances for powered exoskeleton systems are expanding the range of clinically available products, particularly for spinal cord injury and neurological rehabilitation.
- Mobile Systems Gain Traction: Demand is shifting toward wearable systems that support mobility outside controlled rehabilitation environments, including home and community use.
- Asia-Pacific Offers a High-Growth Opportunity: Rising healthcare investment, ageing populations and robotics development are supporting faster adoption of exoskeleton technologies across Asia-Pacific.
Exoskeleton Market Segments
The market sizing and opportunity analysis has been segmented across the following parameters:
By Body Part Covered
- Upper Body
- Lower Body
- Full Body
By Mode of Operation
- Powered
- Passive
- Hybrid
By Form of Exoskeleton
- Rigid
- Soft
By Mobility
- Fixed / Supported
- Mobile
By End User
- Patients
- Healthcare Professionals
- Industry Workers
- Military Personnel
- Others
By Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Rest of the World
Exoskeleton Market: Key Segment Insights
Lower Body Exoskeletons Emerge as a Key Market Growth Segment
Based on our market assessment, the lower body segment currently holds the largest share of the exoskeleton market. This dominance is due to its widespread adoption across rehabilitation, mobility assistance, and industrial use cases. The majority of commercially available exoskeleton systems are designed to restore or augment lower-limb function among individuals with spinal cord injury, stroke, multiple sclerosis, and related neurological or musculoskeletal disorders, underpinning a well-established base of clinical demand. Companies such as Ekso Bionics, ReWalk Robotics (Lifeward), and CYBERDYNE have each commercialized lower-limb exoskeleton platforms that are now widely used across rehabilitation and mobility-assistance settings.The upper body segment is projected to expand at a higher CAGR during the forecast period. This growth is supported by rising deployment across manufacturing, logistics, construction, and healthcare settings aimed at reducing upper-limb fatigue and work-related musculoskeletal disorders. Growing employer awareness of occupational ergonomics, combined with advances in lightweight materials, wearable sensors, and AI-assisted motion control, is improving the comfort and usability of upper body exoskeleton systems and widening their addressable market.
Powered Exoskeletons Emerge as the Leading Operating Mode
Powered exoskeletons currently hold the largest share of the market. This largest share is driven by their superior functional capability relative to passive systems. Powered platforms use electric motors, actuators, or hydraulic mechanisms to assist movement. They are preferred for patients with severe mobility impairments, including spinal cord injury, stroke, and neuromuscular disorders. These platforms have also secured most regulatory clearances and reimbursement support to date. Industrial employers are separately increasing investment in powered systems to reduce worker fatigue and lift productivity in physically demanding roles.The hybrid segment is expected to grow at a higher CAGR through the forecast period, as manufacturers including Ottobock and German Bionic develop architectures that deliver powered assistance only when needed, extending battery life while improving comfort. This trade-off makes hybrid exoskeletons particularly well suited to long-duration industrial shifts, military operations, and rehabilitation programs that do not require continuous powered support.
Rigid Exoskeletons Lead by Form and Soft System are Likely to Grow at a Higher CAGR
Rigid exoskeletons account for the largest share of the market by form. This dominance reflects their established role in medical rehabilitation and industrial load-bearing applications that demand high structural support and precise motion control. These systems deliver superior stability, weight-bearing capacity, and joint alignment, positioning them as the preferred choice for patients with spinal cord injury, stroke, and lower-limb paralysis. Most commercially approved powered exoskeletons available today are rigid in design, reinforcing their market penetration across hospitals, rehabilitation centers, and industrial worksites.Meanwhile, soft exoskeletons are likely to grow at a higher CAGR during the forecast period. This lucrative growth is driven by demand for lightweight, flexible, and ergonomically designed wearable systems that enhance comfort without restricting natural movement. Players such as SUITX (now part of Ottobock) and HeroWear have advanced lightweight systems tailored to occupational ergonomics, while continued innovation in smart textiles and soft robotics is expected to widen clinical applications for soft exoskeleton platforms.
Mobile Exoskeletons Drive Demand Across Mobility Applications
Mobile exoskeletons account for the majority of current market share. This dominance is driven by their broad applicability across rehabilitation, industrial ergonomics, and defense use cases. Unlike fixed or supported systems confined to clinical or laboratory settings, mobile exoskeletons allow users to perform daily activities and rehabilitation exercises in real-world environments, considerably widening their commercial reach. Continued gains in portability, battery life, and AI-based gait assistance are expected to sustain this lead through the forecast period. This growth is largely because manufacturers including Wandercraft and German Bionic extend mobile, autonomous wearable systems into home rehabilitation, industrial operations, and military applications.North America Retains Market Leadership and Asia-Pacific Emerges as the Fastest-Growing Region
North America currently holds the largest share of the market. This dominance is supported by a mature commercialization ecosystem, a comparatively favorable reimbursement landscape for medical exoskeletons, and sustained investment in wearable robotics across healthcare, industrial, and defense applications. The United States has been an early adopter of robotic rehabilitation technology, aided by expanding private-insurer and US Department of Veterans Affairs reimbursement for exoskeleton-assisted gait training among veterans with spinal cord injury. Multiple FDA clearances, together with the presence of leading manufacturers such as Ekso Bionics, ReWalk Robotics (Lifeward), Sarcos Technology and Robotics Corporation, and SuitX (now part of Ottobock), continue to reinforce the region's commercial lead.The Asia-Pacific exoskeleton market is projected to grow at a higher CAGR during the forecast period. This accelerated growth is driven by rapid industrial automation, an aging population, rising incidence of neurological disorders, and expanding government support for robotics and rehabilitation technology. Japan's Robot Care Equipment Development and Introduction Project, backed by the Ministry of Economy, Trade and Industry (METI) and the New Energy and Industrial Technology Development Organization (NEDO), has accelerated commercialization of nursing-care and rehabilitation exoskeletons, while China's 14th Five-Year Plan for Robot Industry Development identifies rehabilitation and medical robotics as strategic growth priorities, encouraging domestic innovation and manufacturing capacity.
Example Players in the Exoskeleton Market
- Bionic Yantra
- CYBERDYNE
- Ekso Bionics
- ExoAtlet
- Fourier Intelligence
- Gloreha
- Guangzhou Yikang Medical Equipment
- Hexar Humancare
- Hocoma
- MediTouch
- Milebot Robotics
- Myomo
- Neofect
- NextStep Robotics
- ReWalk Robotics
- Rex Bionics
- Roam Robotics
- Trexo Robotics
- Tyromotion
- U&O Technologies
Expert and Industry Insights
The opinions and insights presented in this study were shaped by discussions conducted with multiple industry stakeholders. Emphasizing the shift towardsmaller, ergonomics-conscious industrial buyers, Gregory Galarneau, Founder of The Exoskeleton Store, noted that his organization currently serves over 250 customers, with smaller, family-run businesses of 50 employees or fewer emerging as a particularly promising segment given greater owner-level awareness of worker fatigue, simpler internal approval processes, and stronger willingness to invest in employee well-being.The research report features detailed transcripts of interviews held with the following industry stakeholders:
- Co-Founder and Chief Executive Officer, Small Company, Spain
- Director of Business Planning and Development, Small Company, Japan
- Vice President of Sales and Marketing, Small Company, US
- Founder and Director, Small Company, US
- Marketing and Design Manager, Small Company, US
In addition, the report includes transcripts of the following third-party discussions:
- Founder and Chief Executive Officer, Small Company, US / China / Switzerland
- Founder, Small Company, US
- Co-Founder and Chief Scientific Officer, Small Company, US
- Division Head, Small Company, UK
- Scientific Chair, Technology and Innovation, Large Company, US
- Professor and Associate Professor, Large Company, US
- Wearable Robotics Researcher / Engineer, Mid-sized Company, US
EXOSKELETON MARKET: RESEARCH COVERAGE
- Market Sizing and Opportunity Analysis: An in-depth analysis of the exoskeleton market, focused on key market segments, including [A] body part covered, [B] mode of operation, [C] form of exoskeleton, [D] mobility, [E] end user, and [F] key geographical regions.
- Market Landscape: A detailed assessment of the overall exoskeleton device landscape, featuring information on parameters such as body part covered, mode of operation, form, mobility, actuation technology, and regulatory status, along with analysis of developers based on year of establishment, company size, and headquarters location.
- Company Profiles: In-depth profiles of prominent players engaged in the exoskeleton industry, featuring information on year of establishment, headquarters location, company size, management team, product portfolio, and key initiatives.
- Regulatory and Reimbursement Landscape: An analysis of regulatory clearances, reimbursement pathways, and payer coverage trends shaping exoskeleton adoption across key geographies.
- Partnerships and Collaborations Analysis: An assessment of strategic partnerships, collaborations, licensing agreements, technology alliances, and other commercial initiatives undertaken by key players in the exoskeletons market. This analysis helps stakeholders identify emerging business models, technology access opportunities, and potential partnership avenues.
- Funding and Investments Analysis: An evaluation of funding activities and investments across the exoskeletons ecosystem, including venture capital, private equity, grants, corporate investments, and other financing initiatives. The analysis provides insights into capital flows, investor interest, and areas attracting market investment.
- Patent Analysis: A comprehensive assessment of the exoskeletons patent landscape, covering patent applications and publications, jurisdictions, CPC classifications, applicant types, leading patent holders, patent characteristics, citations, and patent valuation. This analysis helps stakeholders assess technological innovation, intellectual property positioning, and competitive differentiation.
- Blue Ocean Strategy Analysis: An evaluation of emerging market opportunities and areas of limited competition within the exoskeletons market. The analysis uses strategy canvas, Pioneer-Migrator-Settler mapping, and Buyer Utility Map frameworks to identify potential avenues for differentiation, unmet customer needs, and new market opportunities.
- Market Impact Analysis: An assessment of the various drivers, restraints, opportunities, and challenges affecting exoskeleton market growth.
KEY QUESTIONS ANSWERED IN THIS REPORT
- Which companies are the leading players in the exoskeleton market?
- Which region dominates the exoskeleton market, and which is growing fastest?
- What are the key trends shaping the exoskeleton market?
- What factors are likely to influence the future evolution of this market?
- What are the primary challenges faced by exoskeleton manufacturers?
- What is the current and future size of the exoskeleton market?
- What is the CAGR of the exoskeleton market through 2035?
- How is market opportunity distributed across body part, mode of operation, form, mobility, and end user segments?
REASONS TO BUY THIS REPORT
- Provides a comprehensive market analysis with detailed revenue projections for the overall exoskeleton market and its specific sub-segments, valuable to both established market leaders and emerging entrants.
- Offers stakeholders a complete overview of the market, including key drivers, barriers, opportunities, and challenges, empowering data-driven decisions to capitalize on growth prospects.
- Helps businesses identify future opportunities across body part, technology, and end-user categories, and evaluate whether those opportunities are worth pursuing.
- Supports identification of customer demand by clarifying the needs, preferences, and behavior of the target audience, enabling more effective product and service tailoring.
- Equips new entrants with the information needed to build successful go-to-market and distribution strategies.
- Enables more effective communication with stakeholders and supports the development of strong business relationships across the exoskeleton value chain.
ADDITIONAL BENEFITS
- Complimentary Excel Data Packs for all analytical modules in the report
- 15% Free Content Customization
- Detailed Report Walkthrough Session with the Research Team
- Complimentary PowerPoint Presentation
- Free Updated Report if the report is 6-12 months old or older
Table of Contents
1. PREFACE
2. RESEARCH METHODOLOGY
3. MARKET DYNAMICS
4. MACRO-ECONOMIC INDICATORS
6. INTRODUCTION
7. MEDICAL EXOSKELETONS: MARKET LANDSCAPE
8. NON-MEDICAL EXOSKELETONS: MARKET LANDSCAPE
9. MEDICAL EXOSKELETONS: PRODUCT COMPETITVENESS ANALYSIS
10. EXOSKELETON DEVELOPERS: DETAILED COMPANY PROFILES
11. EXOSKELETON DEVELOPERS: TABULATED COMPANY PROFILES
12. MEDICAL EXOSKELETONS: PARTNERSHIPS AND COLLABORATIONS
13. PATENT ANALYSIS
14. BLUE OCEAN STRATEGY
15. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
16. GLOBAL EXOSKELETONS MARKET
17. EXOSKELETONS MARKET, BY BODY PART COVERED
18. EXOSKELETONS MARKET, BY MODE OF OPERATION
19. EXOSKELETON MARKETS, BY FORM OF EXOSKELETON
20. EXOSKELETON MARKETS, BY MOBILITY
21. EXOSKELETONS MARKET, BY END USER
22. EXOSKELETONS MARKET, BY KEY GEOGRAPHICAL REGIONS
24. EXECUTIVE INSIGHTS
25. APPENDIX I: BLUE OCEAN STRATEGY AND SHIFT TOOLS
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bionic Yantra
- CYBERDYNE
- Ekso Bionics
- ExoAtlet
- Fourier Intelligence
- Gloreha
- Guangzhou Yikang Medical Equipment
- Hexar Humancare
- Hocoma
- MediTouch
- Milebot Robotics
- Myomo
- Neofect
- NextStep Robotics
- ReWalk Robotics
- Rex Bionics
- Roam Robotics
- Trexo Robotics
- Tyromotion
- U&O Technologies
Methodology
LOADING...
